Immunocore Return On Equity from 2010 to 2024
IMCR Stock | USD 58.10 0.36 0.62% |
Return On Equity | First Reported 2010-12-31 | Previous Quarter (0.15) | Current Value (0.16) | Quarterly Volatility 1.62570701 |
Check Immunocore Holdings financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Immunocore main balance sheet or income statement drivers, such as Interest Expense of 3.6 M, Other Operating Expenses of 324.5 M or Tax Provision of 2.5 M, as well as many exotic indicators such as Price To Sales Ratio of 16 K, Dividend Yield of 0.0 or PTB Ratio of 15.7 K. Immunocore financial statements analysis is a perfect complement when working with Immunocore Holdings Valuation or Volatility modules.
Immunocore | Return On Equity |
Latest Immunocore Holdings' Return On Equity Growth Pattern
Below is the plot of the Return On Equity of Immunocore Holdings over the last few years. Return on Equity is the amount of Immunocore Holdings net income returned as a percentage of Immunocore Holdings equity. Return on equity measures Immunocore Holdings profitability by revealing how much profit Immunocore Holdings generates with the money shareholders have invested. It is a measure of the profitability of a business in relation to the equity, calculated by dividing net income by shareholder's equity. Immunocore Holdings' Return On Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Immunocore Holdings' overall financial position and show how it may be relating to other accounts over time.
View | Last Reported -0.16 | 10 Years Trend |
|
Return On Equity |
Timeline |
Immunocore Return On Equity Regression Statistics
Arithmetic Mean | (1.40) | |
Coefficient Of Variation | (116.16) | |
Mean Deviation | 0.75 | |
Median | (1.27) | |
Standard Deviation | 1.63 | |
Sample Variance | 2.64 | |
Range | 6.8883 | |
R-Value | 0.10 | |
Mean Square Error | 2.82 | |
R-Squared | 0.01 | |
Significance | 0.72 | |
Slope | 0.04 | |
Total Sum of Squares | 37.00 |
Immunocore Return On Equity History
About Immunocore Holdings Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Immunocore Holdings income statement, its balance sheet, and the statement of cash flows. Immunocore Holdings investors use historical funamental indicators, such as Immunocore Holdings's Return On Equity, to determine how well the company is positioned to perform in the future. Although Immunocore Holdings investors may use each financial statement separately, they are all related. The changes in Immunocore Holdings's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Immunocore Holdings's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Immunocore Holdings Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Immunocore Holdings. Please read more on our technical analysis and fundamental analysis pages.
Last Reported | Projected for Next Year | ||
Return On Equity | (0.15) | (0.16) |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out the analysis of Immunocore Holdings Correlation against competitors. To learn how to invest in Immunocore Stock, please use our How to Invest in Immunocore Holdings guide.Note that the Immunocore Holdings information on this page should be used as a complementary analysis to other Immunocore Holdings' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Complementary Tools for Immunocore Stock analysis
When running Immunocore Holdings' price analysis, check to measure Immunocore Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immunocore Holdings is operating at the current time. Most of Immunocore Holdings' value examination focuses on studying past and present price action to predict the probability of Immunocore Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immunocore Holdings' price. Additionally, you may evaluate how the addition of Immunocore Holdings to your portfolios can decrease your overall portfolio volatility.
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |
Is Immunocore Holdings' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Immunocore Holdings. If investors know Immunocore will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Immunocore Holdings listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.68) | Earnings Share (1.41) | Revenue Per Share 5.102 | Quarterly Revenue Growth 0.122 | Return On Assets (0.07) |
The market value of Immunocore Holdings is measured differently than its book value, which is the value of Immunocore that is recorded on the company's balance sheet. Investors also form their own opinion of Immunocore Holdings' value that differs from its market value or its book value, called intrinsic value, which is Immunocore Holdings' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Immunocore Holdings' market value can be influenced by many factors that don't directly affect Immunocore Holdings' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Immunocore Holdings' value and its price as these two are different measures arrived at by different means. Investors typically determine if Immunocore Holdings is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Immunocore Holdings' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.